Data from studies conducted by the Division of Pediatric Infectious Diseases have resulted in changes to both vaccine schedules and therapies for HIV-infected populations. For example, Stony Brook's research on conjugate pneumococcal vaccine in HIV-infected infants resulted in the inclusion of this vaccine in the Advisory Committee on Immunization Practices (ACIP) recommended infant vaccination schedule. In addition, this data from the Stony Brook site was included in the World Health Organization's guidelines for prevention of mother to child transmission of HIV. Other endeavors have resulted in improved adherence to antibiotic prescribing guidelines and novel therapeutics for treatment of tuberculosis.
Pediatric Infectious Diseases Division Chief, Sharon Nachman, MD, has appeared among New York's top doctors listings by Castle Connelly and is a past recipient of the "Changing the Face of Medicine: Local Legends" from New York; for demonstrating commitment, originality, innovation or creativity in the field of medicine. Other awards honoring Dr. Nachman include the Alpha Omega Alpha (AOA) Distinguished Graduate Alumni Award, the Excellence in Teaching Pediatric Residents Award (2001,02,03,06), the 2006 Community Heroes Award by the Pediatric AIDS Clinical Trials Group, and the 2007 Clinical Trial Exceptional Service Award by the Pharmaceutical Research and Manufacturers of America (PhRMA).
Other Division accomplishments include selection by Newsday as Top Doctors in Pediatric Infectious Diseases and Department of Pediatrics faculty awards for Excellence in Patient Care, and recognition for outstanding contributions to student and resident education.